These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2003223)

  • 1. Cisplatin update.
    Muggia FM
    Semin Oncol; 1991 Feb; 18(1 Suppl 3):1-4. PubMed ID: 2003223
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical and clinical experience with cisplatin resistance.
    Marshall JL; Andrews PA
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):415-29. PubMed ID: 7642471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of chemotherapy with platinum compounds.
    Walker EM; Walker SM
    Ann Clin Lab Sci; 1999; 29(4):263-74. PubMed ID: 10528825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiemetic therapy in cisplatin chemotherapy].
    Grünsteidel W; Schmidt C; Tulusan AH; Merkle E
    Gynakol Rundsch; 1989; 29 Suppl 2():374-7. PubMed ID: 2613053
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
    Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
    Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of cisplatin resistance in human carcinomas: model systems and patients.
    Scanlon KJ; Kashani-Sabet M; Miyachi H; Sowers LC; Rossi J
    Anticancer Res; 1989; 9(5):1301-12. PubMed ID: 2686531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fundamental studies with cisplatin.
    Rosenberg B
    Cancer; 1985 May; 55(10):2303-l6. PubMed ID: 3886121
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of cisplatin nephrotoxicity in cancer: adjusting the dosage with a computerized chrono-pump].
    Gestin-Boyer C; René C; Cupissol D; Tep A; Bressolle F; Bres J; Brun S; Serrou B; Pujol H
    C R Seances Soc Biol Fil; 1989; 183(3):263-8. PubMed ID: 2532561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of cisplatin dose intensity: current status and future prospects.
    Gandara DR; Perez EA; Phillips WA; Lawrence HJ; DeGregorio M
    Anticancer Res; 1989; 9(4):1121-8. PubMed ID: 2683991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous treatment with cisplatin and radiation therapy for advanced solid tumors: a pilot study.
    Reimer RR; Gahbauer R; Bukowski RM; Hewlett JS; Groppe CW; Weick JK; Antunez AR
    Cancer Treat Rep; 1981; 65(3-4):219-22. PubMed ID: 7195303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cisplatin].
    Ogawa M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1140-6. PubMed ID: 6326687
    [No Abstract]   [Full Text] [Related]  

  • 12. Nephroprotection by theophylline in patients with cisplatin chemotherapy: a randomized, single-blinded, placebo-controlled trial.
    Benoehr P; Krueth P; Bokemeyer C; Grenz A; Osswald H; Hartmann JT
    J Am Soc Nephrol; 2005 Feb; 16(2):452-8. PubMed ID: 15590762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of cisplatin in combination with glutathione.
    Plaxe S; Freddo J; Kim S; Kirmani S; McClay E; Christen R; Braly P; Howell S
    Gynecol Oncol; 1994 Oct; 55(1):82-6. PubMed ID: 7959273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.
    Sastry J; Kellie SJ
    Pediatr Hematol Oncol; 2005; 22(5):441-5. PubMed ID: 16020136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug.
    Kelland LR; Abel G; McKeage MJ; Jones M; Goddard PM; Valenti M; Murrer BA; Harrap KR
    Cancer Res; 1993 Jun; 53(11):2581-6. PubMed ID: 8388318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
    Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
    Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of cis-DDP in children with refractory malignant tumors].
    Nakadate H; Kobayashi R; Nishi M; Hatae Y; Takeda T; Uchino J; Hirama T; Kobayashi H
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):598-603. PubMed ID: 3954383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cisplatin in the treatment of malignant tumors].
    Wang QL
    Zhonghua Zhong Liu Za Zhi; 1983 Nov; 5(6):461-4. PubMed ID: 6426911
    [No Abstract]   [Full Text] [Related]  

  • 19. Cisplatin, a new antineoplastic drug in veterinary medicine.
    Page R; Matus RE; Leifer CE; Loar A
    J Am Vet Med Assoc; 1985 Feb; 186(3):288-90. PubMed ID: 3918977
    [No Abstract]   [Full Text] [Related]  

  • 20. Cisplatin.
    Dabholkar M; Reed E
    Cancer Chemother Biol Response Modif; 1993; 14():86-97. PubMed ID: 8312126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.